phys.org·Apr 24, 2026
Gene editing holds promise for addressing genetic diseases, but efficiently and safely delivering the editing tools to the appropriate cells at a necessary scale poses significant challenges.
For a professional tracking gene editing and CRISPR advancements, the key insight is the critical need for innovative delivery methods to efficiently and safely target the right cells at therapeutic scales. Focusing on breakthroughs in delivery technologies could be pivotal for overcoming this bottleneck and advancing gene editing applications in clinical settings.